tiprankstipranks
Trending News
More News >
Intellia Therapeutics (DE:38I)
FRANKFURT:38I

Compare Intellia Therapeutics (38I) vs. Competitors

Compare
13 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intellia Therapeutics
€7.82
$927.80M
-29.33%
9 Buy
12 Hold
1 Sell
Moderate Buy
Kura Oncology
$10.63
$925.00M
-4.29
24.91%
10 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.17
$919.55M
-11.30
249.32%
7 Buy
0 Hold
0 Sell
Strong Buy
AbCellera Biologics
$3.58
$1.07B
-6.21
26.95%
4 Buy
1 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$14.25
$857.11M
-8.51
-72.86%
15 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.80
$920.34M
-7.53
-1.18%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:38I
Intellia Therapeutics
7.82
-3.24
-29.33%
KURA
Kura Oncology
10.63
2.12
24.91%
CMPX
Compass Therapeutics
5.17
3.69
249.32%
ABCL
AbCellera Biologics
3.58
0.76
26.95%
JANX
Janux Therapeutics Inc
14.25
-38.25
-72.86%
BCAX
Bicara Therapeutics Inc.
16.80
-0.20
-1.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts